Ace the 2026 RACGP Exam – Get Ready to Rock Your GP Career!

Diclofenac 3% topical treatment is indicated for actinic keratoses because it is a non-steroidal anti-inflammatory drug (NSAID) that has been shown to be effective in the treatment of skin lesions like actinic keratoses. It works by reducing inflammation and has a keratolytic effect, leading to the destruction of the abnormal skin cells. This treatment is non-invasive and is often well tolerated by patients.

Other treatments for actinic keratoses, such as cryotherapy, are effective but are not the only options available. While cryotherapy can be effective in destroying keratotic tissue through freezing, it is often used in conjunction with other treatments rather than standing alone as the only option. Oral isotretinoin is primarily used for severe acne and is not typically indicated for actinic keratoses due to its systemic effects and potential side effects. Topical minoxidil does not have any efficacy against actinic keratoses, as it is primarily used for hair growth stimulation.

Thus, the use of Diclofenac 3% topical treatment specifically aligns with the goal of managing actinic keratoses effectively, making it the appropriate choice among the options provided.